Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells.
Lodi G, Gentili V, Casciano F, Romani A, Zauli G, Secchiero P, Zauli E, Simioni C, Beltrami S, Fernandez M, Rizzo R, Voltan R.
Lodi G, et al. Among authors: zauli e, zauli g.
Front Pharmacol. 2022 Dec 13;13:1018761. doi: 10.3389/fphar.2022.1018761. eCollection 2022.
Front Pharmacol. 2022.
PMID: 36582523
Free PMC article.